202 related articles for article (PubMed ID: 9019647)
1. [Cost of asthma therapy in relation to severity. An empirical study].
Graf von der Schulenburg JM; Greiner W; Molitor S; Kielhorn A
Med Klin (Munich); 1996 Oct; 91(10):670-6. PubMed ID: 9019647
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
[TBL] [Abstract][Full Text] [Related]
3. [Cost-of-illness of asthma in Denmark in the year 2000].
Mossing R; Nielsen GD
Ugeskr Laeger; 2003 Jun; 165(26):2646-9. PubMed ID: 12886546
[TBL] [Abstract][Full Text] [Related]
4. The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care.
Arnlind MH; Nokela M; Rehnberg C; Jonsson EW
J Asthma; 2006 Oct; 43(8):585-91. PubMed ID: 17050222
[TBL] [Abstract][Full Text] [Related]
5. Direct and indirect costs of asthma in Canada, 1990.
Krahn MD; Berka C; Langlois P; Detsky AS
CMAJ; 1996 Mar; 154(6):821-31. PubMed ID: 8634960
[TBL] [Abstract][Full Text] [Related]
6. [Socioeconomic relevance of acute exacerbations of chronic bronchitis in the Federal Republic of Germany. A prospective cost of illness study].
Rychlik R; Pfeil T; Daniel D; Pfeil B; Mast O; Thate-Waschke I; Lorenz J
Dtsch Med Wochenschr; 2001 Mar; 126(13):353-9. PubMed ID: 11332229
[TBL] [Abstract][Full Text] [Related]
7. [A cost of illness study of diabetes mellitus].
von Ferber L; Köster I; Hauner H
Gesundheitswesen; 1997 Jan; 59(1):17-22. PubMed ID: 9138642
[TBL] [Abstract][Full Text] [Related]
8. [A cost analysis of diagnostic screening for the differentiation of type-1 and type-2 diabetics aged 30 to 45. A health economics modelling calculation].
Kilburg A; Bruchhausen Y; Thomas J; Rychlik R
Dtsch Med Wochenschr; 1999 Dec; 124(50):1510-7. PubMed ID: 10633777
[TBL] [Abstract][Full Text] [Related]
9. Costs of drug treatment in Parkinson's disease.
Dodel RC; Eggert KM; Singer MS; Eichhorn TE; Pogarell O; Oertel WH
Mov Disord; 1998 Mar; 13(2):249-54. PubMed ID: 9539337
[TBL] [Abstract][Full Text] [Related]
10. Determinants of health care costs and patterns of care of asthmatic patients in Switzerland.
Szucs TD; Anderhub HP; Rutishauser M
Schweiz Med Wochenschr; 2000 Mar; 130(9):305-13. PubMed ID: 10746270
[TBL] [Abstract][Full Text] [Related]
11. [Compliance and asthma--a delphi survey on therapy compliance by by asthma patients in ambulatory care].
Graf von der Schulenburg JM; Greiner W
Gesundheitswesen; 1998 Oct; 60(10):558-62. PubMed ID: 9844289
[TBL] [Abstract][Full Text] [Related]
12. [Quality assurance of drug therapy for patients with asthma. Health economic analysis].
Søndergaard B; Thorleifsson S; Herborg H; Frøkjaer B; Hepler CD; Ersbøll BK
Ugeskr Laeger; 2000 Jan; 162(4):480-6. PubMed ID: 10697444
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of asthma controller therapies: influence of disease severity and other variables.
Navarro RP; Parasuraman B
Manag Care Interface; 2005 Jun; 18(6):31-40. PubMed ID: 16018297
[TBL] [Abstract][Full Text] [Related]
14. Economic costs for adult asthmatics according to severity and control status in Korean tertiary hospitals.
Kim SH; Kim TW; Kwon JW; Kang HR; Lee YW; Kim TB; Kim SH; Park HW; Park SW; Chang YS; Cho YS; Park JW; Cho YJ; Yoon HJ; Cho SH; Choi BW; Moon HB; Min KU
J Asthma; 2012 Apr; 49(3):303-9. PubMed ID: 22185405
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory therapy reduces total costs of asthma care compared with bronchodilation: the Asthma Outcomes Registry.
Huse DM; Russell MW; Weiss ST; Hartz SC
Am J Manag Care; 2000 Sep; 6(9):1045-50. PubMed ID: 11184066
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study.
Weiss K; Buxton M; Andersson FL; Lamm CJ; Liljas B; Sullivan SD
Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():21-7. PubMed ID: 16573705
[TBL] [Abstract][Full Text] [Related]
17. Cost analysis of GER-induced asthma: a controlled study vs. atopic asthma of comparable severity.
Dal Negro RW; Turco P; Micheletto C; Tognella S; Bonadiman L; Guerriero M; Sandri M
Respir Med; 2007 Aug; 101(8):1814-20. PubMed ID: 17419043
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of the patient-level cost of asthma care in children.
Ungar WJ; Coyte PC;
Pediatr Pulmonol; 2001 Aug; 32(2):101-8. PubMed ID: 11477726
[TBL] [Abstract][Full Text] [Related]
19. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
20. Clinical redesign using all patient refined diagnosis related groups.
Sedman AB; Bahl V; Bunting E; Bandy K; Jones S; Nasr SZ; Schulz K; Campbell DA
Pediatrics; 2004 Oct; 114(4):965-9. PubMed ID: 15466092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
